Comments on “The Efficacy of 12 Weeks of Sofosbuvir, Daclatasvir, and Ribavirin in Treating Hepatitis C Patients with Cirrhosis, Genotypes 1 and 3”
| Author | Babak Sayad | en |
| Author | Fatemeh Norooznezhad | en |
| Author | Alireza Farokhi | en |
| Orcid | Babak Sayad [0000-0001-8686-9986] | en |
| Issued Date | 2017-03-31 | en |
| Abstract | This article does not have an abstract. | en |
| DOI | https://doi.org/10.5812/hepatmon.46588 | en |
| Publisher | Brieflands | en |
| Title | Comments on “The Efficacy of 12 Weeks of Sofosbuvir, Daclatasvir, and Ribavirin in Treating Hepatitis C Patients with Cirrhosis, Genotypes 1 and 3” | en |
| Type | Letter | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- hepatmon-17-03-46588.pdf
- Size:
- 69.25 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF